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1 Introduction
Random coefficient regression (RCR) models were originally introduced in plant and animal
breeding and used for selection purposes (see e. g. Henderson (1984)). The subject of this paper
is the multiple group random coefficient models, in which observational units (individuals) are
allocated in several treatment groups and one control group. In each treatment group some
group-special kind of treatment is available, in the control group there is no treatment. Such
models are typically used for cluster randomization or cluster randomized trials (see e. g. Bland
(2004) or Patton et al. (2006)).
RCR models with known population parameters were considered in detail by Gladitz and Pilz
(1982). Entholzner et al. (2005) investigated optimal designs for estimation of unknown popula-
tion mean parameters in RCR models, where all individuals are observed under the same regime.
Analytical results for designs, which are optimal for the prediction of individual random param-
eters in hierarchical models with the same treatment for all individuals, have been presented in
Prus and Schwabe (2016). A practical approach for computation of optimal approximate and
exact designs was proposed by Harman and Prus (2018).
The fixed effects version of the multiple group models considered in this paper may be recog-
nized as the well known one way layout model. Classical one-way layout models have been well
discussed in the literature. Results for the optimal designs can be found e. g. in Bailey (2008),
Rasch and Herrendörfer (1986), Wierich (1986), Schwabe (1996) or Majumdar and Notz (1983).
Optimal designs for estimation of fixed parameters in multiple group models with random
coefficients were considered e. g. in Fedorov and Jones (2005), Schmelter (2007), Kunert et al.
(2010), Bludowsky et al. (2015) and Lemme et al. (2015). Fedorov and Jones (2005) worked on
optimal designs, which minimize a loss function in multicentre trials models. In Schmelter (2007)
models with the same fixed number of observations in all groups were investigated. Kunert et al.
(2010) proposed a design optimization method based on the generalized least squares estimation.
Bludowsky et al. (2015) considered models with carryover effects. In Lemme et al. (2015) optimal
designs were computed for the maximum likelihood estimation.
Optimal designs for prediction of random effects in models, where the population mean
parameters differ from group to group, were briefly discussed in Prus (2015).
In this paper we investigate multiple group models with the same unknown population pa-
rameters across all groups. We present analytical results for A-, D- and E -optimal designs
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(-optimal group sizes) based on the best linear unbiased estimation or prediction of fixed or
random treatment effects, respectively.
The paper has the following structure: In Section 2 the model will be specified. In Section 3
the best linear unbiased estimation for the population parameters (mean treatment effects) and
a best linear unbiased prediction for the random treatment effects of the observational units will
be discussed. Section 4 provides analytical results for designs, which are optimal for estimation
or prediction. The results will be illustrated by a numerical example, in which we compare the
optimal group sizes in the model under investigation with optimal group sizes in the fixed effects
model (one-way-layout). The paper will be concluded by a discussion of the obtained results and
possible directions for the future research in Section 5.
2 Model Specification
We consider here a multiple group model with J groups and N individuals. In the first J − 1
(treatment) groups individuals get group-special kinds of treatment: 1, . . . , J−1. Each treatment
group includes n > 0 individuals. The last group (group J) is a control group (no treatment)
with m = N − (J − 1)n, m > 0 individuals. The k-th observation at individual i in the j-th
treatment group is given by the following formula:
Yjik = µi + αji + εjik, k = 1, . . . ,K, i = (j − 1)n+ 1, . . . , jn, j = 1, . . . , J − 1, (1)
while in the control group the k-th observation at the i-th individual is given by
YJik = µi + εJik, k = 1, . . . ,K, i = (J − 1)n+ 1, . . . , N, (2)
where K is the number of observations per individual, which is assumed to be the same for all
individuals across all groups, εjik are observational errors with zero expected value and common
variance σ2 > 0.
In this work we optimize the numbers of individuals in treatment and control groups. There-
fore the group allocation of individuals is not completely clear. For this reason we define the
individual treatment effects αji for all individuals and all treatments, i. e. i = 1, . . . , N and
j = 1, . . . , J − 1. For individual i in the control group the treatment effects αji would appear
if the individual would be treated with treatment j. For individual i in treatment group j
the treatment effect αj′i would appear if the individual would get treatment j′ instead of j for
j, j′ = 1, . . . , J − 1, j 6= j′.
Individual intercepts µi are defined for all individual, i. e. i = 1, . . . , N . µi and αji have
unknown expected values E(µi) = µ, E(αji) = αj and variances var(µi) = uσ2, var(αji) =
v σ2 for some given positive values of u and v. All individual parameters µi and αji′ and
all observational errors εj′i′′k, for k = 1, . . . ,K, i, i′ = 1, . . . , N and j, j′, j′′ = 1, . . . , J , are
uncorrelated.
For further considerations we define the regression functions
f(j) :=
{
(1, e>j )
> , j = 1, . . . , J − 1
(1,0>J−1)
> , j = J
,
where ej and 0J−1 denote the j-th unit vector and the zero vector of length J − 1, respectively,
and the total number of individuals
Nj :=
{
nj, j = 1, . . . , J − 1
N, j = J
2
in the first j groups, and we fix N0 by 0. Then for the vector θi := (µi, α1 i, . . . , αJ−1 i)>
of individual random parameters the multiple group model (defined by (1) and (2)) may be
rewritten in the following form:
Yjik = f(j)
>θi + εjik, k = 1, . . . ,K, i = Nj−1 + 1, . . . , Nj , j = 1, . . . , J. (3)
The parameter vectors θi have the expected value E(θi) = θ0 := (µ, α1, . . . , αJ−1)> and the
covariance matrix Cov(θi) = σ2block-diag(u, v IJ−1), where Ip denotes the p× p identity matrix
and block-diag(A1, . . . ,Ap) is the block diagonal matrix with l × l blocks A1, . . . ,Ap.
On the individual level the vectors Yj,i = (Yji1, . . . , YjiK)> for individuals in the j-th group
can be specified as
Yj,i = 1K f(j)
>θi + εj,i, i = Nj−1 + 1, . . . , Nj , j = 1, . . . , J, (4)
where 1K denotes the vector of length K with all entries equal to 1 and εj,i = (εji1, . . . , εjiK)>.
On the group level for the group parameters ϑj := (θ>Nj−1+1, . . . ,θ
>
Nj
)> the vector Yj =
(Y>j, (j−1)n+1, . . . ,Y
>
j,Nj
)> of all observations at all individuals in the j-th group is given by
Yj =
(
Irj ⊗
(
1K f(j)
>
))
ϑj + εj , j = 1, . . . , J, (5)
where
rj :=
{
n , j = 1, . . . , J − 1
m, j = J
,
is the number of individuals in the j-th group, “⊗” denotes the Kronecker product and εj =
(ε>j, (j−1)n+1, . . . , ε
>
j,Nj
)>.
Finally, we introduce the vector of all individual random parameters θ = (ϑ>1 , . . . ,ϑ
>
J )
> (or,
equivalently, θ := (θ>1 , . . . ,θ
>
N )
>), for which the full vector Y = (Y>1 , . . . ,Y>J )
> of observations
at all individuals in all groups is given by the following formula:
Y = DiagJj=1
(
Irj ⊗
(
1K f(j)
>
))
θ + ε, (6)
where Diagps=1(As) is the block diagonal matrix with ls × ts blocks As, s = 1, . . . , p, and ε =
(ε>1 , . . . , ε>J )
>.
Alternatively, for the random vector ζ := θ− (1N ⊗ IJ)θ0 the model (6) can be represented
in the form
Y = VecJj=1
(
1rj ⊗
(
1K f(j)
>
))
θ0 + Diag
J
j=1
(
Irj ⊗
(
1K f(j)
>
))
ζ + ε, (7)
where Vecps=1 (As) = (A
>
1 , . . . ,A
>
p )
> for some ls × t matrices As, s = 1, . . . , p.
Note that ζ = (ζ>1 , . . . , ζ
>
N )
> for ζi = θi − θ0, i = 1, . . . , N . The expected value of ζ is zero
and Cov(ζ) = σ2 IN ⊗ block-diag(u, v IJ−1).
3 Estimation and Prediction
In this chapter we determine the best linear unbiased estimator (BLUE) for the population mean
parameters αj and µ and the best linear unbiased predictor (BLUP) for the individual random
parameters αji and µi for j = 1, . . . , J − 1 and i = 1, . . . , N .
We denote the mean observation in group j by Y¯j = 1rj
∑Nj
i=Nj−1+1 Y¯j,i and the mean obser-
vation at individual i in group j by Y¯j,i = 1K
∑K
k=1 Yjik for all j = 1, . . . , J , i = Nj−1 +1, . . . , Nj .
Then we obtain the following results for the BLUEs of the mean parameters µ and αj and the
BLUPs of the treatment effects µi and αji.
3
Theorem 1. The BLUE for the population intercept parameter µ is given by
µˆ = Y¯J (8)
and the BLUE for the population treatment effect αj is given by
αˆj = Y¯j − Y¯J , j = 1, . . . , J − 1. (9)
Theorem 2. If the i-th individual is in the control group, the BLUP for the individual intercepts
µi is given by
µˆi =
Ku
Ku+ 1
Y¯J,i +
1
Ku+ 1
Y¯J , i = NJ−1 + 1, . . . , N, (10)
otherwise, if the i-th individual is in the j-th treatment group, the BLUP is given by
µˆi =
Ku
K(v + u) + 1
(Y¯j,i − Y¯j) + Y¯J , j = 1, . . . , J − 1, i = Nj−1 + 1, . . . , Nj . (11)
If the i-th individual is in the j-th treatment group, the BLUP for the individual treatment effect
αji is given by
αˆji =
Kv
K(v + u) + 1
(Y¯j,i−Y¯J)+ Ku+ 1
K(v + u) + 1
(Y¯j−Y¯J), j = 1, . . . , J−1, i = Nj−1+1, . . . , Nj
(12)
otherwise the BLUP is given by
αˆji = Y¯j − Y¯J , j = 1, . . . , J − 1, i = 1, . . . , N, i 6= Nj−1 + 1, . . . , Nj . (13)
For the vector Ψ0 := (α1, . . . , αJ−1)> of the mean treatment effects the BLUE is given by
Ψˆ0 = (αˆ1, . . . , αˆJ−1)>.
We denote the vector of all individual treatment effects by Ψ := (Ψ>1 , . . . ,Ψ
>
N )
>, where
Ψi := (α1 i, . . . , αJ−1 i)> is the vector of individual treatment effects for the i-th individual, i =
1, . . . , N . Then the BLUP of Ψ is given by Ψˆ = (Ψˆ
>
1 , . . . , Ψˆ
>
N )
>, where Ψˆi = (αˆ1 i, . . . , αˆJ−1 i)>
is the BLUP for Ψi, i = 1, . . . , N .
The next theorems provide the covariance matrix of Ψˆ0 and the MSE matrix of Ψˆ.
Theorem 3. The covariance matrix of the BLUE Ψˆ0 is given by
Cov
(
Ψˆ0
)
= σ2
(
Ku+ 1
Km
1J−1 1>J−1 +
K(v + u) + 1
Kn
IJ−1
)
. (14)
Theorem 4.
The mean squared error matrix of the BLUP Ψˆ is given by
Cov
(
Ψˆ−Ψ
)
= B1 + B2 + B
>
2 + B3, (15)
where
B1 = σ
21N1
>
N ⊗
(
Ku+ 1
Km
1J−1 1>J−1 +
K(v + u) + 1
Kn
IJ−1
)
,
B2 = −σ2v 1N ⊗
(
tVecJ−1j=1
(
1
n
1>n ⊗
(
eje
>
j
)) ... 0(J−1)×m(J−1)) ,
where 0p×q denotes the p× q zero matrix and tVecps=1 (As) =
(
Vecps=1
(
A>s
))>, and
B3 = σ
2v block-diag
(
In(J−1)2 −
Kv
K(v + u) + 1
DiagJ−1j=1
((
In − 1
n
1n1
>
n
)
⊗
(
eje
>
j
))
, Im(J−1)
)
.
For the proofs of Theorems 1-4 see Appendix A.1.
4
4 Optimal Design
In this chapter we optimize the numbers n and m of individuals in the treatment and control
groups, respectively. We define the exact experimental design as
ξ =
(
1 . . . J − 1 J
n . . . n m
)
, (16)
where the indexes 1, . . . , J − 1 denote the treatment groups and the index J is used for the
control group.
For analytical purposes, we also define the approximate design:
ξ =
(
1 . . . J − 1 J
w . . . w 1− (J − 1)w
)
, w ∈
(
0,
1
J − 1
)
, (17)
where w = nN is the weight of a treatment group and 1 − (J − 1)w = mN is the weight of the
control group. Then only the optimal weight w∗ of a treatment group has to be determined.
4.1 A-criterion
For the estimation of the population treatment effects Ψ0 the A-criterion for an exact design is
defined as the trace of the covariance matrix of the BLUE Ψˆ0:
AΨ0(ξ) = tr
(
Cov
(
Ψˆ0
))
.
We determine the trace of the covariance matrix (14), replace n by Nw and m by N(1−w) and
obtain the next results for an approximate design.
Theorem 5. The A-criterion for the estimation of the population treatment effects Ψ0 is given
for an approximate design by
AΨ0(w) =
σ2(J − 1)
KN
(
K(v + u) + 1
w
+
Ku+ 1
1− (J − 1)w
)
. (18)
Theorem 6. The A-optimal weight w∗A,Ψ0 for the estimation of the population treatment effects
is given by
w∗A,Ψ0 =
1
J − 1 +√J − 1
√
Ku+1
K(v+u)+1
. (19)
Note that for large values of the intercepts variance (u→∞) the optimal weight (19) tends
to the value w∗A,Ψ0 =
1
J−1+√J−1 , which coincides with the optimal weight in the fixed effects
model (see e.g. Bailey (2008), ch. 3 or Schwabe (1996), ch. 3) . If the treatment effects variance
takes a very large value (v → ∞), the limiting optimal design assigns all observations to be
taken in the treatment groups: w∗A,Ψ0 =
1
J−1 . If both variances are large and the variance ratio
b = v/u is fixed, the limiting optimal design is given by
w∗A,Ψ0 =
1
J − 1 +√J − 1
√
1
1+b
.
The A-criterion for the prediction of the individual treatment effects Ψi is defined for an
exact design as the trace of the mean squared error matrix of the BLUP Ψˆ:
AΨ(ξ) = tr
(
Cov
(
Ψˆ−Ψ
))
.
The next theorem presents the A-criterion for an approximate design.
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Theorem 7. The A-criterion for the prediction of the individual treatment effects Ψi is given
for an approximate design by
AΨ(w) = σ
2(J − 1)
(
K(v + u) + 1
Kw
+
Ku+ 1
K(1− (J − 1)w) + v
(
N − 2− Kv (Nw − 1)
K(v + u) + 1
))
. (20)
Proof. The result of Theorem 7 follows from (15) and
tr(B1) =
σ2(J − 1)
K
(
K(v + u) + 1
w
+
Ku+ 1
(1− (J − 1)w)
)
,
tr(B2) = −σ2(J − 1) v
and
tr(B3) = σ
2(J − 1) v
(
N − Kv (Nw − 1)
K(v + u) + 1
)
.
Note that there is no explicit formula for the optimal weight in this case. However, it is easy
to see that there is a unique solution w∗, which may be determined numerically for given values
of N , J , K, u and v. To illustrate the behavior of optimal designs, we consider a numerical
example.
Example 1. Let the total number of individuals be N = 100 and the number of observations
per individual be K = 10 and the variance ratio b = v/u be fixed by the values 2, 0.6 and 0.001.
The next graphics (Figure 1 and Figure 2) illustrate the behavior of the A-optimal weight in
dependence on the treatment effects variance for the special cases of one (left panel) and two
(right panel) treatment groups (J = 2 and J = 3, respectively). The parameter ρ = v/(1 + v) is
used instead of the variance parameter v to cover all values of the treatment effects variance by a
finite interval. On the graphics the solid, dashed and dotted lines present the optimal weight for
the values 2, 0.6 and 0.001 of the ratio b. Note that the optimal weight w∗ takes all its values in
the intervals (0, 1) and (0, 0.5) in the models with one and two treatment groups, respectively.
For the models with one and two treatment groups the optimal the optimal weights start (for
ρ→ 0) at points w∗ = 0.5 and w∗ ≈ 0.29, respectively. This may be explained by the fact that
the optimal designs for the fixed effects models are equal to w∗A,fix =
1
J−1+√J−1 and result in
w∗A,fix = 0.5 for J = 2 and w
∗
A,fix =
1
2+
√
2
≈ 0.29 for J = 3. The optimal weights increase with
increasing variance of the individual treatment effects with limiting values (for ρ→ 1) w∗ = 0.91,
w∗ = 0.80 and w∗ ≈ 0.50 for J = 2 and w∗ = 0.44, w∗ = 0.38 and w∗ ≈ 0.29 for J = 3 for b = 2,
b = 0.6 and b = 0.001, respectively.
Figure 3 and Figure 4 present the efficiency of the optimal weight w∗A,fix from the fixed effects
model for the present model for one (left panel) and two (right panel) treatment groups for the
values 2, 0.6 and 0.001 of the ratio b.
For both particular models the efficiencies start at point 1 and decrease with limits eff = 0.65,
eff = 0.90 and eff ≈ 1 for J = 2 and eff = 0.89, eff = 0.98 and eff ≈ 1 for J = 3 for b = 2, b = 0.6
and b = 0.001.
4.2 D- and E-criterion
In this section we consider D- and E -optimality criteria for the estimation and the prediction in
multiple group models. We consider the general case of model (7) for the estimation of population
parameters and we restrict ourselves to the special case J = 2 for the prediction of individual
treatment effects.
For further considerations we will use the following result.
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Figure 1: A-optimal weight w∗ for one
treatment group and variance ratios
b = 2 (solid line), b = 0.6 (dashed line)
and b = 0.001 (dotted line)
Figure 2: A-optimal weight w∗ for two
treatment groups and variance ratios
b = 2 (solid line), b = 0.6 (dashed line)
and b = 0.001 (dotted line)
Lemma 1. The eigenvalues of the covariance matrix of the BLUE Ψˆ0 are
λ1 =
σ2
K
(
(Ku+ 1)(J − 1)
(N − (J − 1)n) +
K(v + u) + 1
n
)
with algebraic multiplicity 1 and
λ2 =
σ2(K(v + u) + 1)
K n
with algebraic multiplicity J − 2.
Proof. To determine the eigenvalues of the covariance matrix Cov
(
Ψˆ0
)
we solve the equation
det
(
Cov
(
Ψˆ0
)
− λ IJ−1
)
= 0, (21)
where λ denotes an eigenvalue of Cov
(
Ψˆ0
)
.
det
(
Cov
(
Ψˆ0
)
− λ IJ−1
)
= det
(
σ2(Ku+ 1)
K (N − (J − 1)n)1J−1 1
>
J−1 +
(
σ2(K(v + u) + 1)
K n
− λ
)
IJ−1
)
=
(
σ2
K
(
(Ku+ 1)(J − 1)
N − (J − 1)n +
K(v + u) + 1
n
)
− λ
)(
σ2(K(v + u) + 1)
K n
− λ
)J−2
.
Then
λ1 =
σ2
K
(
(Ku+ 1)(J − 1)
(N − (J − 1)n) +
K(v + u) + 1
n
)
and
λ2 =
σ2(K(v + u) + 1)
K n
are the solutions of (21).
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Figure 3: Efficiency of A-optimal de-
sign in fixed effects model for one treat-
ment group and variance ratios b = 2
(solid line), b = 0.6 (dashed line) and
b = 0.001 (dotted line)
Figure 4: Efficiency of A-optimal de-
sign in fixed effects model for two treat-
ment groups and variance ratios b = 2
(solid line), b = 0.6 (dashed line) and
b = 0.001 (dotted line)
For the estimation of the population treatment effects the D-criterion is defined as the loga-
rithm of the determinant of the covariance matrix of the BLUE Ψˆ0:
DΨ0(ξ) = ln det
(
Cov
(
Ψˆ0
))
.
for an exact design. We compute the determinant as the product of the eigenvalues, which are
given in Lemma 1, and receive using n = Nw the following result for approximate designs.
Theorem 8. The D-criterion for the estimation of the population treatment effects Ψ0 is given
for an approximate design by
DΨ0(w) = c+ ln
(
K(v + u) + 1
w
+
(J − 1)(Ku+ 1)
1− (J − 1)w
)
+ (J − 2) ln
(
K(v + u) + 1
w
)
, (22)
where c = (J − 1) ln
(
σ2
KN
)
.
Theorem 9. The D-optimal weight w∗D,Ψ0 for the estimation of the population treatment effects
is given by
w∗D,Ψ0 =
J − 2 + z
(J − 1) (J + z) , (23)
where z =
√
4(J−1)Kv
Ku+1 + J
2.
The E -criterion for the estimation of the population treatment effects is defined for an exact
design as the largest eigenvalue of the covariance matrix of the BLUE Ψˆ0
EΨ0(ξ) = λmax
(
Cov
(
Ψˆ0
))
,
where λmax(A) denotes the largest eigenvalue of the matrix A.
Using Lemma 1 we receive the following form of the E -criterion for approximate designs.
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Theorem 10. The E-criterion for the estimation of the population treatment effects Ψ0 is given
for an approximate design by
EΨ0(w) =
σ2
KN
(
K(v + u) + 1
w
+
(J − 1)(Ku+ 1)
1− (J − 1)w
)
. (24)
Theorem 11. The E-optimal weight w∗E,Ψ0 for the estimation of the population treatment effects
is given by
w∗E,Ψ0 =
1
(J − 1)
(
1 +
√
Ku+1
K(v+u)+1
) . (25)
Note that also for the D- and E -criteria the optimal weights for the estimation of the popula-
tion parameters ((23) and (25)) tend to the optimal weights in the fixed effects model: w∗D,Ψ0 → 1J
and w∗E,Ψ0 → 12(J−1) , for u → ∞. For large values of the treatment effects variance (v → ∞)
all observations should to be taken in the treatment groups: w∗D,Ψ0 = w
∗
E,Ψ0
= 1J−1 . If both
variances are large and b = v/u, the limiting values for the optimal weights are
w∗D,Ψ0 →
J − 2 +√4(J − 1)b+ J2
(J − 1)
(
J +
√
4(J − 1)b+ J2
)
and
w∗E,Ψ0 →
1
(J − 1)
(
1 +
√
1
1+b
) .
For the prediction of the individual treatment effects we consider the particular multiple
group model with one treatment group and one control group (J = 2). In this case the mean
squared error matrix (15) of the prediction simplifies to
Cov
(
Ψˆ−Ψ
)
=
(
H11 H12
H>12 H22
)
, (26)
where
H11 = σ
2(Ku+ 1)
(
N
Knm
1n1
>
n +
v
K(u+ v) + 1
(
In − 1
n
1n1
>
n
))
,
H12 = σ
2(Ku+ 1)
N
Knm
1n1
>
m,
H22 = σ
2
((
K(u+ v) + 1
Kn
+
Ku+ 1
Km
)
1m1
>
m + v Im
)
.
The approximate design (17) simplifies to
ξ =
(
1 2
w 1− w
)
.
The next Lemma provides the eigenvalues of the mean squared error matrix (26).
Lemma 2. The eigenvalues of the mean squared error matrix of the BLUP Ψˆ are
λ1 =
σ2 v (Ku+ 1)
K(v + u) + 1
,
λ2 = σ
2v,
9
λ3 =
σ2
2
(
v
w
+
Ku+ 1
Kw(1− w) +
√
sw
Kw(1− w)
)
,
where sw = K2(1− w)2v2 + 2K(1− w)(1− 2w)(Ku+ 1)v + (Ku+ 1)2, and
λ4 =
σ2
2
(
v
w
+
Ku+ 1
Kw(1− w) −
√
sw
Kw(1− w)
)
with algebraic multiplicities n− 1, m− 1, 1 and 1, respectively.
For the proof see Appendix A.2.
We define the D-criterion for the prediction as the logarithm of the determinant of the mean
squared error matrix of Ψˆ:
DΨ(ξ) = ln det
(
Cov
(
Ψˆ−Ψ
))
.
We compute the determinant using the results of Lemma 2 and obtain the following criterion for
approximate designs.
Theorem 12. The D-criterion for the prediction of the individual treatment effects Ψi is given
for an approximate design by
DΨ(w) = d+N w ln
(
Ku+ 1
K(u+ v) + 1
)
− ln (w (1− w)) , (27)
where d = ln
(
(σ2)NvN−1 (K(u+ v) + 1) 1K
)
.
Theorem 13. The D-optimal weight w∗D,Ψ for the prediction of the individual treatment effects
is given by
w∗D,Ψ =
1
N t
+
1
2
+
√
1
N2 t2
+
1
4
, (28)
where t = ln
(
Ku+1
K(u+v)+1
)
.
We define the E -criterion for the prediction as the largest eigenvalue of the mean squared
error matrix:
EΨ(ξ) = λmax
(
Cov
(
Ψˆ−Ψ
))
.
The E-criterion for approximate designs follows directly from Lemma 2.
Theorem 14. The E-criterion for the prediction of the individual treatment effects Ψi is given
for an approximate design by
EΨ(w) =
σ2
2
(
v
w
+
Ku+ 1
Kw(1− w) +
√
sw
Kw(1− w)
)
. (29)
Theorem 15. The E-optimal weight w∗E,Ψ for the prediction of the individual treatment effects
is given by
w∗E,Ψ =
K(2u+ v) + 2
K(4u+ v) + 4
. (30)
Note that for both D- and E -criteria for the prediction the optimal weights tend to w∗D,Ψ =
w∗E,Ψ = 0.5, which is optimal for the fixed effects model (see e.g. Wierich (1986), p. 44), for
u → ∞ and to w∗D,Ψ = w∗E,Ψ = 1 (all observations are being taken in the treatment group) for
v →∞. For large u, large v and fixed ratio b = v/u we observe
w∗D,Ψ → −
1
N ln(1 + b)
+
1
2
+
√
1
N2 (ln(1 + b))2
+
1
4
10
and
w∗E,Ψ →
2/b+ 1
4/b+ 1
.
Example 2. We consider again the model withN = 100 individuals andK = 10 observations
per individual. The variance ratio b takes the values 2, 0.6 and 0.001 for both D-criterion and
E -criteria. The number of treatment groups is fixed by one (J = 2). The next picture (Figure 5
and Figure 6) illustrates the behavior of the D- (left panel) and E - (right panel) optimal weights
in dependence on the variance parameter ρ.
ρ
w
*
0.0 0.2 0.4 0.6 0.8 1.0
0.45
0.56
0.67
0.78
0.89
1.00
ρ
w
*
0.0 0.2 0.4 0.6 0.8 1.0
0.45
0.50
0.55
0.60
0.65
0.70
Figure 5: D-optimal weight w∗ for vari-
ance ratios b = 2 (solid line), b = 0.6
(dashed line) and b = 0.001 (dotted
line)
Figure 6: E -optimal weight w∗ for vari-
ance ratios b = 2 (solid line), b = 0.6
(dashed line) and b = 0.001 (dotted
line)
As we can observe on the picture the optimal weights start with value w∗ = 0.5, which is
optimal for the fixed effects model for both criteria: w∗D,fix = w
∗
E,fix = 0.5, and increase with
the variance parameter ρ with limiting values w∗ = 0.99, w∗ = 0.98 and w∗ = 0.51 for the
D-criterion and w∗ = 0.67, w∗ = 0.57 and w∗ ≈ 0.5 for the E -criterion for b = 2, b = 0.6 and
b = 0.001, respectively.
On the graphics the values of the optimal designs for the D-criterion are larger than those
for the E -criterion for all ρ and b. The A-optimal designs illustrated by Figure 1 turn out to
take all their values between the corresponding D- and E -optimal weights.
Figure 7 and Figure 8 present the efficiency of the optimal designs from the fixed effects
model for the present model for the D- and E - criteria.
The efficiencies on the picture start at point eff = 1 and decrease with increasing variance
of the individual treatment effects with limiting values eff = 0.60, eff = 0.82 and eff ≈ 1 for the
D- and eff = 0.88, eff = 0.98 and eff ≈ 1 for the E -criterion for b = 2, b = 0.6 and b = 0.001,
respectively.
According to these graphics and Figure 2 the efficiencies for the D-criterion are smaller than
those for the E -criterion and the A-criterion is in between for all values of ρ and b.
Note also that for small values of the variance ratio b the optimal designs are very close to
those in the fixed effects model for all design criteria. Hence, the corresponding efficiencies are
close to 1.
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ρe
ff
0.0 0.2 0.4 0.6 0.8 1.0
0.60
0.68
0.76
0.84
0.92
1.00
ρ
e
ff
0.0 0.2 0.4 0.6 0.8 1.0
0.85
0.88
0.91
0.94
0.97
1.00
Figure 7: Efficiency of D-optimal de-
sign in fixed effects model for variance
ratios b = 2 (solid line), b = 0.6 (dashed
line) and b = 0.001 (dotted line)
Figure 8: Efficiency of E -optimal de-
sign in fixed effects model for variance
ratios b = 2 (solid line), b = 0.6 (dashed
line) and b = 0.001 (dotted line)
5 Discussion and Conclusions
In the present work multiple group RCR models with several treatment groups and a control
group have been considered. We have obtained A-, D- and E -optimality criteria for the estima-
tion of population parameters and for the prediction of individual treatment effects using the
covariance matrix of the BLUE and the mean squared error matrix of the BLUP, respectively.
The optimal designs (optimal group sizes) turned out to be different for the estimation and the
prediction and do not coincide with those in the corresponding fixed-effects-model (one-way-
layout). For large values of the treatment effects variance the optimal designs assign almost all
observations to be taken in the treatment groups. If the variance of the individual intercepts is
large, the optimal groups sizes tend to those in the fixed effects model.
The optimal group sizes are locally optimal, i. e. they depend on the variance parameters.
To avoid this, minimax-optimal designs, which minimize the worst case for the criterion function
over some reasonable region of values of the covariance matrix, or some other design criteria,
which are robust with respect to the variance parameter, may be considered in the next step of
this research.
For the investigated models we assumed a diagonal covariance matrix of random effects.
Models with more complicated covariance structure may also be considered in the future.
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A Appendix
A.1 Proofs of Theorems 1-4
To make use of the available results for estimation and prediction we recognize the model (7) as
a special case of the linear mixed model (see e. g. Christensen (2002))
Y = Xβ + Zγ + ε, (31)
where X and Z are known fixed and random effects design matrices, β and γ are vectors of
fixed and random effects, respectively. The random effects γ and the observational errors ε
are assumed to be uncorrelated and to have zero means and non-singular covariance matrices
G = Cov (γ) and R = Cov (ε).
According to Henderson et al. (1959) for full column rank design matrix X the BLUE βˆ for
β and the BLUP γˆ for γ are provided by the mixed model equations(
βˆ
γˆ
)
=
(
X>R−1X X>R−1Z
Z>R−1X Z>R−1Z + G−1
)−1(
X>R−1Y
Z>R−1Y
)
,
which can be rewritten in the alternative form
βˆ =
(
X>(ZGZ> + R)−1X
)−1
X>(ZGZ> + R)−1Y, (32)
γˆ = GZ>(ZGZ> + R)−1(Y −Xβˆ). (33)
The mean squared error matrix of the estimator and predictor
(
βˆ
>
, γˆ>
)>
is given by (see
Henderson (1975))
Cov
(
βˆ
γˆ − γ
)
=
(
X>R−1X X>R−1Z
Z>R−1X Z>R−1Z + G−1
)−1
and can be represented as the partitioned matrix
Cov
(
βˆ
γˆ − γ
)
=
(
C11 C12
C>12 C22
)
, (34)
where C11 = Cov(βˆ), C22 = Cov (γˆ − γ),
C11 =
(
X>
(
ZGZ> + R
)−1
X
)−1
,
C22 =
(
Z>R−1Z + G−1 − Z>R−1X(X>R−1X)−1X>R−1Z
)−1
,
C12 = −C11 X>R−1Z
(
Z>R−1Z + G−1
)−1
.
For β = θ0, γ = ζ, X = VecJj=1
(
1rj ⊗
(
1K f(j)
>)), Z = DiagJj=1 (Irj ⊗ (1K f(j)>)),
G = σ2 IN ⊗ block-diag(u, IJ−1) and R = Cov(ε) = σ2 INK our model (7) is of form (31).
Using formulas (32) and (33) and after employing some linear algebra we obtain the following
BLUE and BLUP for the fixed and random effects θ0 and ζ:
θˆ0 =
(
Y¯J
VecJ−1j=1
(
Y¯j − Y¯J
) ) ,
13
and
ζˆ =

K
K(v+u)+1 Vec
J−1
j=1 Vec
Nj
i=NJ−1+1
((
u
v ej
)(
Y¯j,i − Y¯j
))
K
Ku+1 Vec
Nj
i=NJ−1+1
((
u
0J−1
)(
Y¯J,i − Y¯J
))
 .
Now the results (8)-(13) of Theorems 1 and 2 are straightforward to verify.
To proof Theorems 3 and 4 we firstly compute the blocks C11, C12 and C22 of the mean
squared error matrix (34):
C11 =
σ2(Ku+ 1)
Km
(
1 −1>J−1
−1J−1 (K(u+v)+1)m(Ku+1)n IJ−1 + 1J−11>J−1
)
(35)
C22 = σ
2
(
C221 0
0 C222
)
, (36)
where
C221 = In(J−1) ⊗ block-diag(u, IJ−1)
− K
K(v + u) + 1
DiagJ−1j=1
((
In − 1
n
1n1
>
n
)
⊗
((
u
v ej
)(
u
v ej
)>))
,
C222 = Im ⊗ block-diag(u, IJ−1)− k
Ku+ 1
(
Im − 1
m
1m1
>
m
)
⊗
((
u
0J−1
)(
u
0J−1
)>)
,
and
C12 = −σ2
(
C121
... C122
)
, (37)
where
C121 = tVec
J−1
j=1
(
1
n
1>n ⊗
((
0
ej
)(
u
vej
)>))
,
C122 =
1
m
1>m ⊗
((
1
−1J−1
)(
u
0J−1
)>)
.
We can observe that Ψ0 = (0J−1
... IJ−1)θ0 and Ψˆ0 = (0J−1
... IJ−1)θˆ0 is the BLUE of Ψ0.
Then the covariance matrix of Ψˆ0 can be determined using the formula
Cov
(
Ψˆ0
)
= (0J−1
... IJ−1)C11(0J−1
... IJ−1)>,
which implies result (14).
For the vector Ψ of all individual treatment effects it cam be verified that
Ψ =
(
1N ⊗ (0J−1
... IJ−1)
)
θ0 +
(
IN ⊗ (0J−1
... IJ−1)
)
ζ
14
and the BLUP of Ψ is given by
Ψˆ =
(
1N ⊗ (0J−1
... IJ−1)
)
θˆ0 +
(
IN ⊗ (0J−1
... IJ−1)
)
ζˆ.
Then the mean squared error matrix of Ψˆ is of general form (15) with
B1 =
(
1N ⊗ (0J−1
... IJ−1)
)
C11
(
1N ⊗ (0J−1
... IJ−1)
)>
,
B2 =
(
1N ⊗ (0J−1
... IJ−1)
)
C12
(
IN ⊗ (0J−1
... IJ−1)
)>
and
B3 =
(
IN ⊗ (0J−1
... IJ−1)
)
C22
(
IN ⊗ (0J−1
... IJ−1)
)>
.
After applying (35)-(37) we obtain the result of Theorem 4.
A.2 Proof of Lemma 2
To determine the eigenvalues of Cov
(
Ψˆ−Ψ
)
, we have to solve the equation
det
(
Cov
(
Ψˆ−Ψ
)
− λ IN
)
= 0. (38)
From (26) it follows that
Cov
(
Ψˆ−Ψ
)
− λ IN =:
(
H˜11 H12
H>12 H˜22
)
,
where
H˜11 = (a1 − λ) 1
n
1n1
>
n + (a2 − λ)
(
In − 1
n
1n1
>
n
)
for a1 =
σ2N(Ku+1)
Km and a2 =
σ2 v (Ku+1)
K(v+u)+1 ,
H˜22 = a3
1
m
1m1
>
m + (σ
2v − λ)Im
for a3 =
σ2(K(v+u)+1)m
K n +
a1m
N , and H12 is the same as in (26).
Then we compute the determinant of Cov
(
Ψˆ−Ψ
)
− λ IN as
det
(
Cov
(
Ψˆ−Ψ
)
− λ IN
)
= det
(
H˜11
)
det
(
H˜22 −H>12 H˜−111 H12
)
,
where
det
(
H˜11
)
= (a1 − λ)(a2 − λ)n−1,
H˜−111 =
1
a1 − λ
1
n
1n1
>
n +
1
a2 − λ
(
In − 1
n
1n1
>
n
)
,
H˜22 −H>12 H˜−111 H12 =
(
a3 − a
2
1m
(a1 − λ)n
)
1
m
1m1
>
m +
(
σ2v − λ) Im,
det
(
H˜22 −H>12 H˜−111 H12
)
=
(
σ2v − λ)m−1(a3 − a21m
(a1 − λ)n + σ
2v − λ
)
.
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Then we obtain
det
(
Cov
(
Ψˆ−Ψ
)
− λ IN
)
= (a2 − λ)n−1
(
σ2v − λ)m−1((a3 + σ2v − λ)(a1 − λ)− a21m
n
)
,
which results in the following solutions of equation (38):
λ1 =
σ2 v (Ku+ 1)
K(v + u) + 1
,
λ2 = σ
2v,
λ3 =
σ2N
2Knm
(Kmv +N(Ku+ 1) +
√
sn,m),
where sn,m = K2m2v2 + 2Km(m− n)(Ku+ 1)v +N2(Ku+ 1)2, and
λ4 =
σ2N
2Knm
(Kmv +N(Ku+ 1)−√sn,m).
After applying n = N w and m = N(1−w) we can see that sn,m = N2sw and obtain the results
of the lemma.
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